Association of OPRD1 Gene Variants with Changes in Body Weight and Psychometric Indicators in Patients with Eating Disorders

<b>Objectives</b>: This study aimed to investigate whether genetic variations in the <i>OPRD1</i> gene affect psychopathological symptoms and personality dimensions in eating disorders (ED) patients and/or contribute to ED risk. <b>Methods</b>: The study involved 221 female patients with anorexia nervosa (AN), 88 with bulimia nervosa (BN), and 396 controls. Sixteen tag-single nucleotide polymorphisms (SNPs) in <i>OPRD1</i> were identified. Psychometric evaluations were conducted using the Symptom Checklist 90 Revised (SCL-90R) and the Eating Disorders Inventory Test-2 (EDI-2). <i>p</i>-values obtained by regression models were corrected for multiple testing by the False Discovery Rate (FDR) method. <b>Results</b>: In AN patients, genotypes rs204077TT and rs169450TT were linked to lower body-mass index (BMI) values (FDR-q = 0.035 and 0.017, respectively), as was rs2234918 in a log-additive model (BMI: 18.0 ± 0.28, 17.22 ± 0.18 and 16.59 ± 0.39 for TT, TC and CC carriers, FDR-q = 0.012). Additionally, AN patients carrying the rs72665504AA genotype had higher scores in interpersonal distrust (FDR-q = 0.030), whilst BN carriers of rs513269TT and rs2873795TT showed lower scores in ineffectiveness (FDR-q = 0.041 and FDR-q = 0.021). In the AN group, BMI correlated with variability in a distal haplotype (rs508448/rs204077/rs223491, FDR-q = 0.028), which was also associated with the global positive symptom total (PST) index of SCL-90R (FDR-q = 0.048). Associations were more noticeable in BN patients; again, the distal region of the gene was linked to EDI-2 total scores (FDR-q = 0.004-0.048 for the four last haplotypes) and two global SCL-90R indices (GSI: FDR-q = 0.011 and positive symptom distress index (PSDI): FDR-q = 0.003 for the last s204077/rs2234918/rs169450 combination). No associations with ED risk were observed. <b>Conclusions</b>: Genetic variation in the <i>OPRD1</i> gene, particularly in its distal region, is associated with BMI and psychopathological comorbidities in ED patients.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2024-09-01
DOI
https://doi.org/10.3390/jcm13175189
Primary Topic
Eating Disorders and Behaviors
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of OPRD1 Gene Variants with Changes in Body Weight and Psychometric Indicators in Patients with Eating Disorders

Luz María González, Sonia Mota-Zamorano, Guillermo Gervasini, Laura González-Rodríguez et al.
Journal of Clinical Medicine
Eating Disorders and Behaviors
article

Association of OPRD1 Gene Variants with Changes in Body Weight and Psychometric Indicators in Patients with Eating Disorders

Luz María González, Sonia Mota-Zamorano, Guillermo Gervasini, Laura González-Rodríguez, Angustias García‐Herráiz, Isalud Flores
article en

Abstract

<b>Objectives</b>: This study aimed to investigate whether genetic variations in the <i>OPRD1</i> gene affect psychopathological symptoms and personality dimensions in eating disorders (ED) patients and/or contribute to ED risk. <b>Methods</b>: The study involved 221 female patients with anorexia nervosa (AN), 88 with bulimia nervosa (BN), and 396 controls. Sixteen tag-single nucleotide polymorphisms (SNPs) in <i>OPRD1</i> were identified. Psychometric evaluations were conducted using the Symptom Checklist 90 Revised (SCL-90R) and the Eating Disorders Inventory Test-2 (EDI-2). <i>p</i>-values obtained by regression models were corrected for multiple testing by the False Discovery Rate (FDR) method. <b>Results</b>: In AN patients, genotypes rs204077TT and rs169450TT were linked to lower body-mass index (BMI) values (FDR-q = 0.035 and 0.017, respectively), as was rs2234918 in a log-additive model (BMI: 18.0 ± 0.28, 17.22 ± 0.18 and 16.59 ± 0.39 for TT, TC and CC carriers, FDR-q = 0.012). Additionally, AN patients carrying the rs72665504AA genotype had higher scores in interpersonal distrust (FDR-q = 0.030), whilst BN carriers of rs513269TT and rs2873795TT showed lower scores in ineffectiveness (FDR-q = 0.041 and FDR-q = 0.021). In the AN group, BMI correlated with variability in a distal haplotype (rs508448/rs204077/rs223491, FDR-q = 0.028), which was also associated with the global positive symptom total (PST) index of SCL-90R (FDR-q = 0.048). Associations were more noticeable in BN patients; again, the distal region of the gene was linked to EDI-2 total scores (FDR-q = 0.004-0.048 for the four last haplotypes) and two global SCL-90R indices (GSI: FDR-q = 0.011 and positive symptom distress index (PSDI): FDR-q = 0.003 for the last s204077/rs2234918/rs169450 combination). No associations with ED risk were observed. <b>Conclusions</b>: Genetic variation in the <i>OPRD1</i> gene, particularly in its distal region, is associated with BMI and psychopathological comorbidities in ED patients.

Journal of Clinical MedicineVol. 13(17)
Universidad de Extremadura (ES)
Instituto de Salud Carlos III
Good health and well-being
Openalex Percentile: Top 80%
Eating Disorders and Behaviors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.